A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors
Status:
Not yet recruiting
Trial end date:
2025-03-03
Target enrollment:
Participant gender:
Summary
This study is looking at how Mim8 works compared to other medicines in children with
haemophilia A, who either have inhibitors or do not have inhibitors.
Mim8 is a new medicine that will be used for prevention of bleeds. Mim8 will be injected with
a thin needle into the skin. The study will last for about 54-98 weeks, from screening to
follow-up visit, In case the participant experiences bleeds, these can be treated with
additional haemostatic medicine as agreed with the study doctor.